🧵 4. Revenue growth also fueled by newer drugs like Mounjaro, Eli Lilly's Type 2 diabetes injection, with sales of $979.7 million in Q2, up from $16 million in the year-ago period.
You are viewing a single comment's thread from:
🧵 4. Revenue growth also fueled by newer drugs like Mounjaro, Eli Lilly's Type 2 diabetes injection, with sales of $979.7 million in Q2, up from $16 million in the year-ago period.